Covered recipient · General Payments record
NAISSAN O WESLEY
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$34,471.89
- Reported across 228 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $10,894.00 | 1 |
| Food and Beverage | $956.83 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Evolved By Nature, Inc. | $10,894.00 | 1 |
| ABBVIE INC. | $302.98 | 10 |
| REVANCE THERAPEUTICS, INC. | $192.54 | 5 |
| Janssen Biotech, Inc. | $188.57 | 4 |
| Galderma Laboratories, L.P. | $125.54 | 1 |
| Almirall LLC | $51.00 | 2 |
| Incyte Corporation | $45.00 | 2 |
| MERZ NORTH AMERICA, INC. | $30.99 | 1 |
| Amgen Inc. | $20.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.83 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327475 | CMS |
| ABBVIE INC. | $29.83 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327477 | CMS |
| ABBVIE INC. | $26.77 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327479 | CMS |
| ABBVIE INC. | $29.23 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327481 | CMS |
| ABBVIE INC. | $24.92 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327483 | CMS |
| ABBVIE INC. | $32.48 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327485 | CMS |
| ABBVIE INC. | $31.13 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327487 | CMS |
| ABBVIE INC. | $33.93 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327489 | CMS |
| ABBVIE INC. | $34.16 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327491 | CMS |
| ABBVIE INC. | $30.70 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106327493 | CMS |
| Almirall LLC | $25.00 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120636031 | CMS |
| Almirall LLC | $26.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120636219 | CMS |
| Amgen Inc. | $20.21 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117716118 | CMS |
| Evolved By Nature, Inc. | $10,894.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142344854 | CMS |
| Galderma Laboratories, L.P. | $125.54 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145335127 | CMS |
| Incyte Corporation | $15.98 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141280816 | CMS |
| Incyte Corporation | $29.02 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141280944 | CMS |
| Janssen Biotech, Inc. | $118.77 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078307588 | CMS |
| Janssen Biotech, Inc. | $26.92 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078308600 | CMS |
| Janssen Biotech, Inc. | $20.59 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078308054 | CMS |
| Janssen Biotech, Inc. | $22.29 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078306196 | CMS |
| MERZ NORTH AMERICA, INC. | $30.99 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146373608 | CMS |
| REVANCE THERAPEUTICS, INC. | $2.02 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931729 | CMS |
| REVANCE THERAPEUTICS, INC. | $22.19 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931731 | CMS |
| REVANCE THERAPEUTICS, INC. | $55.93 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931733 | CMS |
| REVANCE THERAPEUTICS, INC. | $74.40 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931735 | CMS |
| REVANCE THERAPEUTICS, INC. | $38.00 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931738 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.